Targeting Interleukin-22 in Psoriasis (original) (raw)

• Nestle, F.O., D.H. Kaplan, and J. Barker. 2009. Psoriasis. New England Journal of Medicine 361: 496–509.
  Article CAS PubMed Google Scholar
• Voorhees, J.J. 1977. Pathophysiology of psoriasis. Annual Review of Medicine 28: 467–473.
  Article CAS PubMed Google Scholar
• Pan, H.F., R.X. Leng, C.C. Feng, et al. 2013. Expression profiles of Th17 pathway related genes in human systemic lupus erythematosus. Molecular Biology Reports 40: 391–399.
  Article CAS PubMed Google Scholar
• Zhao, X.F., H.F. Pan, H. Yuan, et al. 2010. Increased serum interleukin 17 in patients with systemic lupus erythematosus. Molecular Biology Reports 37: 81–85.
  Article PubMed CAS Google Scholar
• Chung, Y., X. Yang, S.H. Chang, et al. 2006. Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes. Cell Research 16: 902–907.
  Article CAS PubMed Google Scholar
• Liang, S.C., X.Y. Tan, D.P. Luxenberg, et al. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. Journal of Experimental Medicine 203: 2271–2279.
  Article CAS PubMed PubMed Central Google Scholar
• Duhen, T., R. Geiger, D. Jarrossay, et al. 2009. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nature Immunology 10: 857–863.
  Article CAS PubMed Google Scholar
• Trifari, S., C.D. Kaplan, E.H. Tran, et al. 2009. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nature Immunology 10: 864–871.
  Article CAS PubMed Google Scholar
• Pan, H.F., X.P. Li, S.G. Zheng, et al. 2012. Emerging role of interleukin-22 in autoimmune diseases. Cytokine & Growth Factor Reviews 24: 51–57.
  Article CAS Google Scholar
• Wolk, K., E. Witte, K. Warszawska, et al. 2009. The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis. European Journal of Immunology 39: 3570–3581.
  Article CAS PubMed Google Scholar
• Liu, H., K. Huang, Y. Wu, et al. 2007. The expression of interleukin-22 and S100A7, A8, A9 mRNA in patients with psoriasis vulgaris. Journal of Huazhong University of Science and Technology. Medical Sciences 27: 605–607.
  Article CAS Google Scholar
• Ouyang, W. 2010. Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease. Cytokine & Growth Factor Reviews 21: 435–441.
  Article CAS Google Scholar
• Sabat, R. 2010. IL-10 family of cytokines. Cytokine & Growth Factor Reviews 21: 315–324.
  Article CAS Google Scholar
• Wolk, K., and R. Sabat. 2006. Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine & Growth Factor Reviews 17: 367–380.
  Article CAS Google Scholar
• Wolk, K., S. Kunz, E. Witte, et al. 2004. IL-22 increases the innate immunity of tissues. Immunity 21: 241–254.
  Article CAS PubMed Google Scholar
• Fujita, H., K.E. Nograles, T. Kikuchi, et al. 2009. Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production. Proceedings of the National Academy of Sciences of the United States of America 106: 21795–21800.
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, N., Pan, H. F. & Ye, D. Q. Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention. Mol Cell Biochem 353, 41–6
• Simonian, P. L., Wehrmann, F., Roark, C. L., et al. γδ T cells protect against lung fibrosis via IL-22. J Exp Med 207, 2239–53.
• Cella, M., A. Fuchs, W. Vermi, et al. 2009. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457: 722–725.
  Article CAS PubMed Google Scholar
• Guo, H. & Topham, D. J. Interleukin-22 (IL-22) production by pulmonary natural killer cells and the potential role of IL-22 during primary influenza virus infection. J Virol 84, 7750–9.
• Zenewicz, L. A. & Flavell, R. A. Recent advances in IL-22 biology. Int Immunol 23, 159–63.
• Cupedo, T., N.K. Crellin, N. Papazian, et al. 2009. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nature Immunology 10: 66–74.
  Article CAS PubMed Google Scholar
• Takatori, H., Y. Kanno, W.T. Watford, et al. 2009. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. Journal of Experimental Medicine 206: 35–41.
  Article CAS PubMed PubMed Central Google Scholar
• Lejeune, D., L. Dumoutier, S. Constantinescu, et al. 2002. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. Journal of Biological Chemistry 277: 33676–33682.
  Article CAS PubMed Google Scholar
• Dumoutier, L., J. Louahed, and J.C. Renauld. 2000. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. Journal of Immunology 164: 1814–1819.
  Article CAS Google Scholar
• Zheng, Y., D.M. Danilenko, P. Valdez, et al. 2007. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445: 648–651.
  Article CAS PubMed Google Scholar
• Tagoe, C., and C. Putterman. 2012. JAK2 inhibition in murine systemic lupus erythematosus. Immunotherapy 4: 369–372.
  Article CAS PubMed Google Scholar
• Jia, Y., J. Jing, Y. Bai, et al. 2011. Amelioration of experimental autoimmune encephalomyelitis by plumbagin through down-regulation of JAK-STAT and NF-kappaB signaling pathways. PLoS One 6: e27006.
  Article CAS PubMed PubMed Central Google Scholar
• Jiang, Z., H. Li, D.C. Fitzgerald, et al. 2009. MOG(35–55) i.v suppresses experimental autoimmune encephalomyelitis partially through modulation of Th17 and JAK/STAT pathways. European Journal of Immunology 39: 789–799.
  Article CAS PubMed PubMed Central Google Scholar
• Arumugam, S., R.A. Thandavarayan, P.T. Veeraveedu, et al. 2012. Involvement of AMPK and MAPK signaling during the progression of experimental autoimmune myocarditis in rats and its blockade using a novel antioxidant. Experimental and Molecular Pathology 93: 183–189.
  Article CAS PubMed Google Scholar
• Noubade, R., D.N. Krementsov, R. Del Rio, et al. 2011. Activation of p38 MAPK in CD4 T cells controls IL-17 production and autoimmune encephalomyelitis. Blood 118: 3290–3300.
  Article CAS PubMed PubMed Central Google Scholar
• Mitra, A., R.S. Fallen, and H.C. Lima. 2012. Cytokine-based therapy in psoriasis. Clinical Reviews in Allergy & Immunology 44: 173–182.
  Article CAS Google Scholar
• Nograles, K.E., L.C. Zaba, E. Guttman-Yassky, et al. 2008. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. British Journal of Dermatology 159: 1092–1102.
  CAS PubMed Google Scholar
• Pan, H.F., X.F. Zhao, H. Yuan, et al. 2009. Decreased serum IL-22 levels in patients with systemic lupus erythematosus. Clinica Chimica Acta 401: 179–180.
  Article CAS Google Scholar
• Qin, W.Z., L.L. Chen, H.F. Pan, et al. 2011. Expressions of IL-22 in circulating CD4+/CD8+ T cells and their correlation with disease activity in SLE patients. Clinical and Experimental Medicine 11: 245–250.
  Article CAS PubMed Google Scholar
• Lavoie, T.N., C.M. Stewart, K.M. Berg, et al. 2011. Expression of interleukin-22 in Sjogren's syndrome: significant correlation with disease parameters. Scandinavian Journal of Immunology 74: 377–382.
  Article CAS PubMed PubMed Central Google Scholar
• Caproni, M., E. Antiga, L. Melani, et al. 2009. Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial. Journal of Clinical Immunology 29: 210–214.
  Article CAS PubMed Google Scholar
• Lo, Y.H., K. Torii, C. Saito, et al. 2010. Serum IL-22 correlates with psoriatic severity and serum IL-6 correlates with susceptibility to phototherapy. Journal of Dermatological Science 58: 225–227.
  Article CAS PubMed Google Scholar
• Nakajima, H., K. Nakajima, M. Tarutani, et al. 2011. Kinetics of circulating Th17 cytokines and adipokines in psoriasis patients. Archives of Dermatological Research 303: 451–455.
  Article CAS PubMed PubMed Central Google Scholar
• Meephansan, J., K. Ruchusatsawat, W. Sindhupak, et al. 2011. Effect of methotrexate on serum levels of IL-22 in patients with psoriasis. European Journal of Dermatology 21: 501–504.
  Article CAS PubMed Google Scholar
• Sabat, R., and K. Wolk. 2011. Research in practice: IL-22 and IL-20: significance for epithelial homeostasis and psoriasis pathogenesis. Journal der Deutschen Dermatologischen Gesellschaft 9: 518–523.
  PubMed Google Scholar
• Wolk, K., H.S. Haugen, W. Xu, et al. 2009. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J Mol Med (Berl) 87: 523–536.
  Article CAS Google Scholar
• Boniface, K., F.X. Bernard, M. Garcia, et al. 2005. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. Journal of Immunology 174: 3695–3702.
  Article CAS Google Scholar
• Van Belle, A.B., M. de Heusch, M.M. Lemaire, et al. 2012. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice. Journal of Immunology 188: 462–469.
  Article CAS Google Scholar
• Pantelyushin, S., S. Haak, B. Ingold, et al. 2012. Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice. Journal of Clinical Investigation 122: 2252–2256.
  Article CAS PubMed PubMed Central Google Scholar
• Ma, H.L., S. Liang, J. Li, et al. 2008. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. Journal of Clinical Investigation 118: 597–607.
  CAS PubMed PubMed Central Google Scholar
• Krueger, J.G. 2012. Hiding under the skin: a welcome surprise in psoriasis. Nature Medicine 18: 1750–1751.
  Article CAS PubMed Google Scholar